A clearer understanding of glaucoma Glaucoma is one of the leading causes of vision loss and blindness worldwide. In glaucoma patients, the optic nerve, which relays information from the eye to the brain, is damaged, though the molecular cause of nerv…
Category: News
Brilliant Blue G Recalled Because of Fungal Contamination
A pharmacy in Florida is recalling lots of Brilliant Blue G ophthalmic solution because of the development of fungal endophthalmitis in some patients. News Alerts
Clinical Notes: Foodborne Illness Toll Soars
(MedPage Today) — Reports from a CDC-sponsored conference painted a grim picture of increasing deaths and illnesses from ingested pathogens over the past decade. Also this week: kids skip out on allergy treatments.
Retinopathy Tied to Cognitive Decline (CME/CE)
(MedPage Today) — The eye of the patient may hold clues to the risk of dementia, researchers reported.
DMEI chooses ifa EMR v6 as its future Electronic Medical Record system
ifa united i-tech, a U.S. subsidiary of ifa Systems AG, the global leader for IT solutions in ophthalmology, announced that the Dean McGee Eye Institute (DMEI) selected ifa EMR v6 as its future Electronic Medical Record (EMR) system.
Einstein members celebrate 2012 Match Day
Members of Albert Einstein College of Medicine of Yeshiva University’s graduating class celebrated another strong year for residency placements in competitive specialties and prestigious programs at this year’s Match Day. Representing the culmination o…
Should All African Americans Get Glaucoma Screening?
Screening middle-aged African Americans for glaucoma may prevent some from losing their vision, but the benefits are modest and costly, suggests a new study. Reuters Health Information
Blood Vessel Disease Of Retina May Be Marker Of Cognitive Decline
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the Universit…
ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of o…
Retinopathy May Signal Impending Cognitive Decline
A study links retinopathy to subsequent cognitive impairment and ischemic brain changes in healthy older women. Medscape Medical News
Eye Disease As Marker Of Brain Health
A new US study suggests that screening for retinopathy, a disease of blood vessels in the retina at the back of the eye, could serve as a marker for brain health, after researchers found that women aged 65 and over with even a mild form of the diseas…
Glaucoma May Involve Entire Visual Pathway, Not Just Eye
Glaucoma, seen as a disease of high intraocular pressure, may involve neurodegeneration along the entire visual pathway. Possible protective, regenerative, and neuroenhancing strategies are proposed. Medscape Medical News
Scientists grow rudimentary retina structure from blood cells
For the first time, scientists at the University of Wisconsin-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells derived from human blood.
Brain And Eye Abnormalities In Astronauts Caused By Prolonged Space Travel
Magnetic resonance imaging (MRI) of the eyes and brains of 27 astronauts who have spent prolonged periods of time in space revealed optical abnormalities similar to those that can occur in intracranial hypertension of unknown cause, a potentially serio…
Ophthalmologists Receive New Genetic Testing Guidelines
The American Academy of Ophthalmology has published guidelines inspired by the growth in direct-to-consumer marketing of genetic tests. Medscape Medical News
Glaucoma Screens Urged for Blacks (CME/CE)
(MedPage Today) — Routine screening of older African Americans for glaucoma would significantly reduce the incidence of blindness at relatively low cost, researchers said.
Glaucoma Screening Program Likely Benefit Middle Aged African-Americans
According to a computer-based mathematical model in the March issue of the JAMA journal Archives of Ophthalmology, middle-aged African-American patients may benefit from a routine national glaucoma screening program. However, the test’s potential effec…
Positive results from Bausch + Lomb, NicOx BOL‑303259‑X phase 2b study on OAG
Bausch + Lomb, the global eye health company, and NicOx S.A. today announced positive top-line results from the phase 2b study conducted with BOL‑303259‑X, a novel nitric oxide-donating prostaglandin F2‑alpha analog, in patients with open-angle g…
Canaloplasty Safe, But Not as Effective as Trabeculectomy
Canaloplasty had fewer postoperative complications but was not as effective as trabeculectomy for glaucoma. Medscape Medical News
Glaucoma Drug Preservatives: ‘Disease’ or ‘Minimal’ Problem?
Ophthalmologists convened by a drug company claim adverse reactions to glaucoma drugs amount to a disease, but an independent expert rejects this view. Medscape Medical News